ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$1.76 USD
-0.06 (-3.30%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.77 +0.01 (0.57%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.03 |
Last EPS Surprise | 75.00% |
ABR | 1.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.31 |
Next Year | -0.42 |
EPS (TTM) | -0.29 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.75M | 15.66M | 23.29M | 25.61M |
# of Estimates | 1 | 1 | 3 | 3 |
High Estimate | 4.75M | 15.66M | 32.54M | 46.28M |
Low Estimate | 4.75M | 15.66M | 12.10M | 12.20M |
Year ago Sales | 1.49M | 3.54M | 7.04M | 23.29M |
Year over Year Growth Est. | 218.79% | 342.37% | 230.73% | 9.96% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.07 | -0.31 | -0.42 |
# of Estimates | 2 | 2 | 4 | 3 |
Most Recent Consensus | -0.15 | -0.15 | -0.28 | -0.51 |
High Estimate | -0.09 | 0.02 | -0.21 | -0.26 |
Low Estimate | -0.15 | -0.15 | -0.44 | -0.51 |
Year ago EPS | -0.08 | -0.08 | -0.38 | -0.31 |
Year over Year Growth Est. | -50.00% | 12.50% | 18.42% | -35.48% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.07 | -0.31 | -0.42 |
7 Days Ago | -0.12 | -0.07 | -0.31 | -0.42 |
30 Days Ago | -0.12 | -0.07 | -0.31 | -0.42 |
60 Days Ago | -0.12 | -0.06 | -0.37 | -0.47 |
90 Days Ago | -0.12 | -0.06 | -0.37 | -0.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.07 | -0.31 | -0.42 |
Zacks Consensus Estimate | -0.12 | -0.07 | -0.31 | -0.42 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.03 | -0.10 | -0.08 | -0.08 | NA |
Estimate | -0.12 | -0.12 | -0.08 | -0.06 | NA |
Difference | 0.09 | 0.02 | 0.00 | -0.02 | 0.02 |
Surprise | 75.00% | 16.67% | 0.00% | -33.33% | 14.59% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more